Skip to main content
SpringerLink
Log in

Diabetes Management in Latin America

  • Chapter
  • First Online:
The Diabetes Textbook

Abstract

Diabetes is a global public health issue disproportionally affecting low- and middle-income countries like those in Latin America and the Caribbean. Exclusively focusing on Latin America and the Caribbean, in this chapter, we summarize the epidemiology of diabetes (type 1 and type 2), including prevalence and incidence estimates, temporal trends, and drivers. We also elaborate on the epidemiology of diabetes-related complications, both microvascular and macrovascular. This epidemiological knowledge is relevant to design and implement policies as well as interventions to improve diabetes care in Latin America and the Caribbean. In this line, we summarize and provide key examples of intervention for primary, secondary and tertiary prevention of diabetes; similarly, we provide outstanding examples of implementation science projects in Latin America and the Caribbean and discuss know-do-gaps. Treatment is a cornerstone of diabetes management, and we describe evidence about the access to hypoglycaemic medication and medication for cardiovascular prevention. Finally, we elaborate on novel tools (e.g. diagnostic and prognostic scores) as well as future research trends about diabetes in Latin America and the Caribbean.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Patterson CC, Karuranga S, Salpea P, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.

    Article  PubMed  Google Scholar 

  2. Aschner P. Diabetes trends in Latin America. Diabetes Metab Res Rev. 2002;18(Suppl 3):S27–31.

    Article  PubMed  Google Scholar 

  3. Coutinho WF, Silva Junior WS. Diabetes care in Brazil. Ann Glob Health. 2015;81(6):735–41.

    Article  PubMed  Google Scholar 

  4. Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020;8(3):226–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Negrato CA, Lauris JRP, Saggioro IB, et al. Increasing incidence of type 1 diabetes between 1986 and 2015 in Bauru, Brazil. Diabetes Res Clin Pract. 2017;127:198–204.

    Article  PubMed  Google Scholar 

  6. Wacher NH, Gomez-Diaz RA, Ascencio-Montiel IJ, Rascon-Pacheco RA, Aguilar-Salinas CA, Borja-Aburto VH. Type 1 diabetes incidence in children and adolescents in Mexico: data from a nation-wide institutional register during 2000-2018. Diabetes Res Clin Pract. 2020;159:107949.

    Article  PubMed  Google Scholar 

  7. Gomez-Diaz RA, Perez-Perez G, Hernandez-Cuesta IT, et al. Incidence of type 1 diabetes in Mexico: data from an institutional register 2000-2010. Diabetes Care. 2012;35(11):e77.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Carrasco E, Angel B, Codner E, et al. [Type 1 diabetes mellitus incidence in Santiago, Chile. Analysis by counties in the period 2000-2004]. Rev Med Chil. 2006;134(10):1258–64.

    Google Scholar 

  9. Garfias CP, Borzutzky A, Ugarte MF, Garcia HJ, Phingsthorn M, Garcia HG. Mandatory notifications of type 1 diabetes incident cases in Chilean children, 2006 to 2014: a population-based study. Pediatr Diabetes. 2020;21(1):48–52.

    Article  CAS  PubMed  Google Scholar 

  10. Collado-Mesa F, Barcelo A, Arheart KL, Messiah SE. An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America. Rev Panam Salud Publica. 2004;15(6):388–94.

    Article  PubMed  Google Scholar 

  11. Gomez-Lopera N, Alfaro JM, Leal SM, Pineda-Trujillo N. Type 1 diabetes loci display a variety of native American and African ancestries in diseased individuals from Northwest Colombia. World J Diabetes. 2019;10(11):534–45.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gomes MB, Gabrielli AB, Santos DC, et al. Self-reported color-race and genomic ancestry in an admixed population: a contribution of a nationwide survey in patients with type 1 diabetes in Brazil. Diabetes Res Clin Pract. 2018;140:245–52.

    Article  PubMed  Google Scholar 

  13. Gonzalez RN, Torres-Aviles F, Carrasco PE, Salas PF, Perez BF. [Association of the incidence of type 1 diabetes mellitus with environmental factors in Chile during the period 2000-2007]. Rev Med Chil. 2013;141(5):595–601.

    Google Scholar 

  14. Laron Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4–7.

    Article  PubMed  Google Scholar 

  15. Alves JG, Figueiroa JN, Meneses J, Alves GV. Breastfeeding protects against type 1 diabetes mellitus: a case-sibling study. Breastfeed Med. 2012;7(1):25–8.

    Article  PubMed  Google Scholar 

  16. Alhazmi A, Sane F, Lazrek M, et al. Enteroviruses and type 1 diabetes mellitus: an overlooked relationship in some regions. Microorganisms. 2020;8(10):1458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lisboa HR, Graebin R, Butzke L, Rodrigues CS. Incidence of type 1 diabetes mellitus in Passo Fundo, RS, Brazil. Braz J Med Biol Res. 1998;31(12):1553–6.

    Article  CAS  PubMed  Google Scholar 

  18. Torres-Aviles F, Carrasco E, Icaza G, Perez-Bravo F. Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis. Acta Diabetol. 2010;47(3):251–7.

    Article  PubMed  Google Scholar 

  19. Mejia-Leon ME, Ruiz-Dyck KM, Calderon de la Barca AM. HLA-DQ genetic risk gradient for type 1 diabetes and celiac disease in northwestern Mexico. Rev Gastroenterol Mex. 2015;80(2):135–43.

    CAS  PubMed  Google Scholar 

  20. Mimbacas A, Garcia L, Zorrilla P, et al. Genotype and phenotype correlations in diabetic patients in Uruguay. Genet Mol Res. 2009;8(4):1352–8.

    Article  CAS  PubMed  Google Scholar 

  21. Pineda-Trujillo N, Rodriguez-Acevedo A, Rodriguez A, et al. RNASEH1 gene variants are associated with autoimmune type 1 diabetes in Colombia. J Endocrinol Invest. 2018;41(7):755–64.

    Article  CAS  PubMed  Google Scholar 

  22. Maiti AK, Kim-Howard X, Viswanathan P, et al. Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatology (Oxford). 2010;49(7):1239–44.

    Article  CAS  PubMed  Google Scholar 

  23. Maiti AK, Kim-Howard X, Viswanathan P, et al. Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum. 2010;62(2):323–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pizarro C, Garcia-Diaz DF, Codner E, Salas-Perez F, Carrasco E, Perez-Bravo F. PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile. Diabetes Metab Res Rev. 2014;30(8):761–6.

    Article  CAS  PubMed  Google Scholar 

  25. Mattana TC, Santos AS, Fukui RT, et al. CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort. Mediators Inflamm. 2014;2014:694948.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Brandao LC, Vatta S, Guimaraes R, et al. Rapid genetic screening for major human leukocyte antigen risk haplotypes in patients with type 1 diabetes from Northeastern Brazil. Hum Immunol. 2010;71(3):277–80.

    Article  CAS  PubMed  Google Scholar 

  27. Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res Clin Pract. 2007;77(1):134–40.

    Article  CAS  PubMed  Google Scholar 

  28. Santos JL, Perez-Bravo F, Carrasco E, Calvillan M, Albala C. Association between HLA-DQB1 alleles and type 1 diabetes in a case-parents study conducted in Santiago, Chile. Am J Epidemiol. 2001;153(8):794–8.

    Article  CAS  PubMed  Google Scholar 

  29. Santos DC, Porto LC, Oliveira RV, et al. HLA class II genotyping of admixed Brazilian patients with type 1 diabetes according to self-reported color/race in a nationwide study. Sci Rep. 2020;10(1):6628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. de Oliveira Rassi T, Xavier Pietra R, Melo Silva Canton J, Novato Silva I. Temporal trend of newly diagnosed type 1 diabetes children and adolescents identified over a 35-year period in a Brazilian institution. Diabetes Res Clin Pract. 2019;151:82–7.

    Article  PubMed  Google Scholar 

  31. Beran D, Yudkin JS. Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract. 2010;88(3):217–21.

    Article  PubMed  Google Scholar 

  32. Cobas RA, Bosi Ferraz M, Matheus AS, et al. Heterogeneity in the costs of type 1 diabetes in a developing country: what are the determining factors? Diabetol Metab Syndr. 2013;5(1):83.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Faradji-Hazan RN, Valenzuela-Lara M, Diaz-Barriga Menchaca AP, et al. Type 1 diabetes care in Mexico: an analysis of the RENACED-DT1 National Registry. Rev Invest Clin. 2021;73(4):222–30.

    CAS  PubMed  Google Scholar 

  34. Gagliardino JJ, de la Hera M, Siri F, Grupo de Investigacion de la Red Q. [Evaluation of the quality of care for diabetic patients in Latin America]. Rev Panam Salud Publica. 2001;10(5):309–17.

    Google Scholar 

  35. Gomes MB, Coral M, Cobas RA, et al. Prevalence of adults with type 1 diabetes who meet the goals of care in daily clinical practice: a nationwide multicenter study in Brazil. Diabetes Res Clin Pract. 2012;97(1):63–70.

    Article  PubMed  Google Scholar 

  36. Jose LP, Cardoso-Demartini Ade A, Liberatore Junior RD, et al. Clinical and laboratory profile of pediatric and adolescent patients with type 1 diabetes. J Pediatr (Rio J). 2009;85(6):490–4.

    Article  PubMed  Google Scholar 

  37. Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6671 adults with diabetes in Brazil. Acta Diabetol. 2010;47(2):137–45.

    Article  PubMed  Google Scholar 

  38. Gomes MB, Negrato CA. Adherence to insulin therapeutic regimens in patients with type 1 diabetes. A nationwide survey in Brazil. Diabetes Res Clin Pract. 2016;120:47–55.

    Article  CAS  PubMed  Google Scholar 

  39. Altamirano-Bustamante N, Islas-Ortega L, Robles-Valdes C, et al. Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2008;21(12):1163–8.

    Article  PubMed  Google Scholar 

  40. Cobas RA, Ferraz MB, Matheus AS, et al. The cost of type 1 diabetes: a nationwide multicentre study in Brazil. Bull World Health Organ. 2013;91(6):434–40.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Cardenas MK, Miranda JJ, Beran D. Delivery of type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru. Diabet Med. 2016;33(6):752–60.

    Article  CAS  PubMed  Google Scholar 

  42. Gomes MB, Santos DC, Pizarro MH, et al. Relationship between health care insurance status, social determinants and prevalence of diabetes-related microvascular complications in patients with type 1 diabetes: a nationwide survey in Brazil. Acta Diabetol. 2019;56(6):697–705.

    Article  PubMed  Google Scholar 

  43. Gomes MB, Rodacki M, Pavin EJ, et al. The impact of ethnicity, educational and economic status on the prescription of insulin therapeutic regimens and on glycemic control in patients with type 1 diabetes. A nationwide study in Brazil. Diabetes Res Clin Pract. 2017;134:44–52.

    Article  PubMed  Google Scholar 

  44. Andrade C, Alves CAD. Influence of socioeconomic and psychological factors in glycemic control in young children with type 1 diabetes mellitus. J Pediatr (Rio J). 2019;95(1):48–53.

    Article  PubMed  Google Scholar 

  45. Gomes MB, Cobas RA, Matheus AS, et al. Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group. Diabetol Metab Syndr. 2012;4(1):44.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Gomes MB, de Mattos Matheus AS, Calliari LE, et al. Economic status and clinical care in young type 1 diabetes patients: a nationwide multicenter study in Brazil. Acta Diabetol. 2013;50(5):743–52.

    Article  CAS  PubMed  Google Scholar 

  47. Andrade CS, Ribeiro GS, Santos C, Neves RCS, Moreira ED Jr. Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil. BMJ Open. 2017;7(12):e018094.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Araujo MB, Mazza CS. Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina. Pediatr Diabetes. 2008;9(5):480–7.

    Article  PubMed  Google Scholar 

  49. Gonzalez-Aguero M, Chenhall R, Basnayake P, Vaughan C. Inequalities in the age of universal health coverage: young Chileans with diabetes negotiating for their right to health. Med Anthropol Q. 2020;34(2):210–26.

    Article  PubMed  Google Scholar 

  50. Moreira ED Jr, Neves RC, Nunes ZO, et al. Glycemic control and its correlates in patients with diabetes in Venezuela: results from a nationwide survey. Diabetes Res Clin Pract. 2010;87(3):407–14.

    Article  PubMed  Google Scholar 

  51. Melo LGN, Morales PH, Drummond KRG, et al. Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil. BMC Public Health. 2018;18(1):989.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Gomes MB, Almeida AP, Santos DC, Leao E, Cunha EF, Negrato CA. Cause-specific mortality in a cohort of Brazilian patients with type 1 diabetes. Acta Diabetol. 2017;54(6):535–42.

    Article  PubMed  Google Scholar 

  53. Weinert LS, Scheffel RS, Severo MD, et al. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96(1):29–34.

    Article  PubMed  Google Scholar 

  54. Barreto SM, Miranda JJ, Figueroa JP, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol. 2012;41(2):557–71.

    Article  PubMed  PubMed Central  Google Scholar 

  55. United Nations Development Programme. Regional human development report for Latin America and the Caribbean, 2010: acting on the future: breaking the intergenerational transmission of inequality; 2010.

    Google Scholar 

  56. Cardona D, Acosta LD, Bertone CL. Inequidades en salud entre países de Latinoamérica y el Caribe (2005-2010). Gaceta Sanitaria. 2013;27(4):292–7.

    Article  PubMed  Google Scholar 

  57. Jiwani SS, Carrillo-Larco RM, Hernández-Vásquez A, et al. The shift of obesity burden by socioeconomic status between 1998 and 2017 in Latin America and the Caribbean: a cross-sectional series study. Lancet Glob Health. 2019;7(12):e1644–54.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Dávila-Cervantes CA, Agudelo-Botero M. Health inequalities in Latin America: persistent gaps in life expectancy. Lancet Planet Health. 2019;3(12):e492–3.

    Article  PubMed  Google Scholar 

  59. (NCD-RisC) NRFC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.

    Article  Google Scholar 

  60. Institute for Health Metrics and Evaluation (IHME). GBD compare data vizualization [Internet]. [cited 2021 Jul 1]. http://vizhub.healthdata.org/gbd-compare.

  61. International Diabetes Federation. IDF Diabetes Atlas. Brussels: International Diabetes Federation; 2019.

    Google Scholar 

  62. Miranda JJ, Carrillo-Larco RM, Ferreccio C, et al. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet Glob Health. 2020;8(1):e123–33.

    Article  Google Scholar 

  63. Duncan BB, Cousin E, Naghavi M, et al. The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017. Popul Health Metr. 2020;18(Suppl 1):9.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Barquera S, Hernández-Barrera L, Trejo B, Shamah T, Campos-Nonato I, Rivera-Dommarco J. Obesidad en México, prevalencia y tendencias en adultos. Ensanut 2018-19. Salud Pública de México. 2020;62(6):682–92.

    Article  PubMed  Google Scholar 

  65. Carrillo-Larco RM, Pearson-Stuttard J, Bernabe-Ortiz A, Gregg EW. The Andean Latin-American burden of diabetes attributable to high body mass index: a comparative risk assessment. Diabetes Res Clin Pract. 2020;160:107978.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med. 2015;81:445–50.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Carrillo-Larco RM, Bernabé-Ortiz A. Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general. Revista peruana de medicina experimental y salud publica. 2019;36(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Schmidt MI, Bracco PA, Yudkin JS, et al. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil. Lancet Diabetes Endocrinol. 2019;7(4):267–77.

    Article  PubMed  Google Scholar 

  69. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  PubMed Central  Google Scholar 

  70. Ludwig J, Sanbonmatsu L, Gennetian L, et al. Neighborhoods, obesity, and diabetes—a randomized social experiment. N Engl J Med. 2011;365(16):1509–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Spencer Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don’t talk about when we talk about preventing type 2 diabetes—addressing socioeconomic disadvantage. JAMA Intern Med. 2016;176(8):1053.

    Article  PubMed  Google Scholar 

  72. Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.

    Article  Google Scholar 

  73. Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922.

    Article  Google Scholar 

  74. Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–70.

    Article  PubMed  Google Scholar 

  75. Arredondo A. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Med. 2014;12(1):136.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: a systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev. 2019;35(4):e3139.

    Article  PubMed  Google Scholar 

  77. Avilés-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes across the continent. Curr Diab Rep. 2020;20(11):62.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Popkin BM, Reardon T. Obesity and the food system transformation in Latin America: obesity and food system transformation. Obes Rev. 2018;19(8):1028–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Rivera-Andrade A, Luna MA. Trends and heterogeneity of cardiovascular disease and risk factors across Latin American and Caribbean countries. Prog Cardiovasc Dis. 2014;57(3):276–85.

    Article  PubMed  Google Scholar 

  80. Mercader JM, Florez JC. The genetic basis of type 2 diabetes in Hispanics and Latin Americans: challenges and opportunities. Front Public Health. 2017;5:329.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Campbell DD, Parra MV, Duque C, et al. Amerind ancestry, socioeconomic status and the genetics of type 2 diabetes in a Colombian population. PLoS One. 2012;7(4):e33570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Wissow LS. Diabetes, poverty, and Latin America. Patient Educ Couns. 2006;61(2):169–70.

    Article  PubMed  Google Scholar 

  83. Gallardo-Rincón H, Cantoral A, Arrieta A, et al. Review: type 2 diabetes in Latin America and the Caribbean: regional and country comparison on prevalence, trends, costs and expanded prevention. Prim Care Diabetes. 2021;15(2):352–9.

    Article  PubMed  Google Scholar 

  84. Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400–20.

    Article  PubMed  Google Scholar 

  85. Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195–206.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Bowling FL, Rashid ST, Boulton AJ. Preventing and treating foot complications associated with diabetes mellitus. Nat Rev Endocrinol. 2015;11(10):606–16.

    Article  PubMed  Google Scholar 

  87. Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9(12):713–23.

    Article  CAS  PubMed  Google Scholar 

  88. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.

    Article  CAS  PubMed  Google Scholar 

  89. Irving R, Tusié-Luna MT, Mills J, Wright-Pascoe R, McLaughlin W, Aguilar-Salinas CA. Early onset type 2 diabetes in Jamaica and in Mexico. Opportunities derived from an interethnic study. Rev Invest Clin. 2011;63(2):198–209.

    PubMed  Google Scholar 

  90. Gagliardino JJ, de la Hera M, Siri F. [Evaluation of the quality of care for diabetic patients in Latin America]. Rev Panam Salud Publica. 2001;10(5):309–17.

    Google Scholar 

  91. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.

    Article  PubMed  Google Scholar 

  92. Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020;43(5):964–74.

    Article  PubMed  Google Scholar 

  93. Jost BS, Hilgemberg E, Rodrigues EB, Daniotti AF, Bonamigo EL. [Prevalence of diabetic retinopathy in patients affected by type 2 diabetes mellitus in the city of Luzerna--SC]. Arquivos brasileiros de oftalmologia. 2010;73(3):259–65.

    Google Scholar 

  94. Schellini SA, Carvalho GM, Rendeiro FS, Padovani CR, Hirai FE. Prevalence of diabetes and diabetic retinopathy in a Brazilian population. Ophthalmic Epidemiol. 2014;21(1):33–8.

    Article  PubMed  Google Scholar 

  95. Cardoso CRL, Leite NC, Moram CBM, Salles GF. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc Diabetol. 2018;17(1):33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Del Brutto OH, Mera RM, King NR, Zambrano M, Sullivan LJ. The burden of diabetes-related foot disorders in community-dwellers living in rural Ecuador: results of the Atahualpa Project. Foot (Edinburgh, Scotland). 2016;28:26–9.

    PubMed  Google Scholar 

  97. Minderhoud J, Pawiroredjo JC, Bueno de Mesquita-Voigt AM, et al. Diabetes and diabetic retinopathy in people aged 50 years and older in the Republic of Suriname. Br J Ophthalmol. 2016;100(6):814–8.

    Article  PubMed  Google Scholar 

  98. Acevedo Castellón RI, Carranza Vargas E, Cortés Chavarría RE, Rodríguez Vargas GA. Rapid assessment of avoidable blindness and diabetic retinopathy in individuals aged 50 years or older in Costa Rica. PLoS One. 2019;14(2):e0212660.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Polack S, Yorston D, López-Ramos A, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology. 2012;119(5):1033–40.

    Article  PubMed  Google Scholar 

  100. Lopez-Ramos A, Gomez-Bastar PA, Lansingh VC, et al. Rapid assessment of avoidable blindness: prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014. Ophthalmic Epidemiol. 2018;25(5–6):412–8.

    Article  PubMed  Google Scholar 

  101. Centers for Disease Control and Prevention (CDC). Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes---United States and Puerto Rico, 1996-2007. MMWR Morb Mortal Wkly Rep. 2010;59(42):1361–6.

    Google Scholar 

  102. Burrows NR, Hora I, Williams DE, Geiss LS. Trends in incidence of end-stage renal disease among persons with diagnosed diabetes--Puerto Rico, 1996-2010. MMWR Morb Mortal Wkly Rep. 2014;63(9):186–9.

    PubMed  PubMed Central  Google Scholar 

  103. Carro GV, Saurral R, Sagüez FS, Witman EL. [Diabetic foot among hospitalized patients in Latin America]. Medicina. 2018;78(4):243–51.

    Google Scholar 

  104. Carro GV, Saurral R, Salvador Sagüez F, et al. Estudio de diabetes mellitus y pie diabético en la internación: datos de argentina. Revista de la Sociedad Argentina de Diabetes. 2019;53(1).

    Google Scholar 

  105. Parisi MC, Moura Neto A, Menezes FH, et al. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016;8:25.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Silva J, Haddad M, Rossaneis MA, Vannuchi MTO, Marcon SS. Factors associated with foot ulceration of people with diabetes mellitus living in rural areas. Revista gaucha de enfermagem. 2017;38(3):e68767.

    PubMed  Google Scholar 

  107. Cisneros-González N, Ascencio-Montiel IJ, Libreros-Bango VN, et al. [Lower extremity amputation rates in diabetic patients]. Revista medica del Instituto Mexicano del Seguro Social. 2016;54(4): 472–9.

    Google Scholar 

  108. Salamanca O, Geary A, Suárez N, Benavent S, Gonzalez M. Implementation of a diabetic retinopathy referral network, Peru. Bull World Health Organ. 2018;96(10):674–81.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Ramos W, López T, Revilla L, More L, Huamaní M, Pozo M. [Results of the epidemiological surveillance of diabetes mellitus in hospitals in Peru, 2012]. Revista peruana de medicina experimental y salud publica. 2014;31(1):9–15.

    Google Scholar 

  110. Chen-Ku CH, Gonzalez-Galvez G, Vásquez M, et al. Vascular complications in patients with type 2 diabetes: prevalence and comorbidities in 6 countries of Latin America (a cohort of the discover study program). Endocr Pract. 2019;25(10):994–1002.

    Article  PubMed  Google Scholar 

  111. Silva H, Hernandez-Hernandez R, Vinueza R, et al. Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther. 2010;17(2):159–66.

    Article  PubMed  Google Scholar 

  112. Bello-Chavolla OY, Aguilar-Salinas CA. Diabetes in Latin America. In: Dagogo-Jack S, editor. Diabetes mellitus in developing countries and underserved communities. Cham: Springer International Publishing; 2017. p. 101–26.

    Chapter  Google Scholar 

  113. Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 2019;16(3):e1002751.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Barcelo A, Cafiero E, De Boer M, et al. Using collaborative learning to improve diabetes care and outcomes: the VIDA project. Prim Care Diabetes. 2010;4(3):145–53.

    Article  PubMed  Google Scholar 

  115. Pacheco APF, Sande-Lee Svd, Sandoval RdCB, Batista S, Marques JLB. Effects of a structured education program on glycemic control in type 1 diabetes. Arch Endocrinol Metab. 2017;61(6):534–41.

    Google Scholar 

  116. Bechara GM, Castelo Branco F, Rodrigues AL, et al. “KiDS and Diabetes in Schools” project: experience with an international educational intervention among parents and school professionals. Pediatr Diabetes. 2018;19(4):756–60.

    Article  PubMed  Google Scholar 

  117. Magalhaes TPC, Foscolo RB, Soares AN, Reis JS. Type 1 diabetes mellitus: can coaching improve health outcomes? Arch Endocrinol Metab. 2018;62(4):485–9.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Barengo NC, Acosta T, Arrieta A, et al. Early lifestyle interventions in people with impaired glucose tolerance in Northern Colombia: the DEMOJUAN Project. Int J Environ Res Public Health. 2019;16(8):1403.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Pimentel GD, Portero-McLellan KC, Oliveira EP, et al. Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance. Nutr Res. 2010;30(3):186–90.

    Article  CAS  PubMed  Google Scholar 

  120. Cezaretto A, Siqueira-Catania A, de Barros CR, Salvador EP, Ferreira SR. Benefits on quality of life concomitant to metabolic improvement in intervention program for prevention of diabetes mellitus. Qual Life Res. 2012;21(1):105–13.

    Article  PubMed  Google Scholar 

  121. Carrasco F, Moreno M, Irribarra V, et al. [Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes]. Rev Med Chil. 2008;136(1):13–21.

    Google Scholar 

  122. Armenta-Guirado B, Martínez-Contreras T, Candia-Plata MC, et al. Effectiveness of the diabetes prevention program for obesity treatment in real world clinical practice in a middle-income country in Latin America. Nutrients. 2019;11(10):2324.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Gagliardino JJ, Lapertosa S, Pfirter G, et al. Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med. 2013;30(9):1102–11.

    Article  CAS  PubMed  Google Scholar 

  124. Grillo Mde F, Neumann CR, Scain SF, et al. Diabetes education in primary care: a randomized clinical trial. Cad Saude Publica. 2016;32(5):S0102-311X2016000500502.

    PubMed  Google Scholar 

  125. Partapsingh VA, Maharaj RG, Rawlins JM. Applying the stages of change model to type 2 diabetes care in Trinidad: a randomised trial. J Negat Results Biomed. 2011;10:13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. de Sousa MV, Fukui R, Krustrup P, et al. Positive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes. Scand J Med Sci Sports. 2014;24(Suppl 1):57–65.

    Article  PubMed  Google Scholar 

  127. West-Pollak A, Then EP, Podesta C, et al. Impact of a novel community-based lifestyle intervention program on type 2 diabetes and cardiovascular risk in a resource-poor setting in the Dominican Republic. Int Health. 2014;6(2):118–24.

    Article  PubMed  Google Scholar 

  128. Rosales CB, Denman CA, Bell ML, et al. Meta Salud Diabetes for cardiovascular disease prevention in Mexico: a cluster-randomized behavioural clinical trial. Int J Epidemiol. 2021;50(4):1272–82.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Aráuz AG, Sánchez G, Padilla G, Fernández M, Roselló M, Guzmán S. [Community diabetes educational intervention at the primary care level]. Rev Panam Salud Publica. 2001;9(3):145–53.

    Google Scholar 

  130. Mendoza-Romo MA, Velasco-Chávez JF, Nieva de Jesús RN, Andrade-Rodríguez Hde J, Rodríguez-Pérez CV, Palou-Fraga E. [Impact of an educational institutional program in the control of the diabetic patient]. Revista medica del Instituto Mexicano del Seguro Social. 2013;51(3):254–9.

    Google Scholar 

  131. Lew KN, McLean Y, Byers S, Taylor H, Braizat OM. Combined diabetes prevention and disease self-management intervention for Nicaraguan ethnic minorities: a pilot study. Prog Community Health Partnersh. 2017;11(4):357–66.

    Article  PubMed  Google Scholar 

  132. Micikas M, Foster J, Weis A, et al. A community health worker intervention for diabetes self-management among the Tz’utujil Maya of Guatemala. Health Promot Pract. 2015;16(4):601–8.

    Article  PubMed  Google Scholar 

  133. do Valle Nascimento TM, Resnicow K, Nery M, et al. A pilot study of a Community Health Agent-led type 2 diabetes self-management program using motivational interviewing-based approaches in a public primary care center in São Paulo, Brazil. BMC Health Serv Res. 2017;17(1):32.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Lazo-Porras M, Bernabe-Ortiz A, Taype-Rondan A, et al. Foot thermometry with mHeath-based supplementation to prevent diabetic foot ulcers: a randomized controlled trial. Wellcome Open Res. 2020;5:23.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Anzaldo-Campos MC, Contreras S, Vargas-Ojeda A, Menchaca-Díaz R, Fortmann A, Philis-Tsimikas A. Dulce Wireless Tijuana: a randomized control trial evaluating the impact of Project Dulce and short-term mobile technology on glycemic control in a Family Medicine Clinic in Northern Mexico. Diabetes Technol Ther. 2016;18(4):240–51.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Piette JD, Mendoza-Avelares MO, Ganser M, Mohamed M, Marinec N, Krishnan S. A preliminary study of a cloud-computing model for chronic illness self-care support in an underdeveloped country. Am J Prev Med. 2011;40(6):629–32.

    Article  PubMed  Google Scholar 

  137. Miranda JJ, Lazo-Porras M, Bernabe-Ortiz A, et al. The effect of individual and mixed rewards on diabetes management: a feasibility randomized controlled trial. Wellcome Open Res. 2018;3:139.

    Article  PubMed  Google Scholar 

  138. Rodriguez AE, Rodriguez Alemparte M, Fernandez Pereira C, et al. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. Am Heart J. 2005;150(1):188.

    Article  PubMed  Google Scholar 

  139. Eccles MP, Mittman BS. Welcome to implementation science. Implement Sci. 2006;22:1.

    Article  Google Scholar 

  140. Bauer MS, Kirchner J. Implementation science: what is it and why should I care? Psychiatry Res. 2020;283:112376.

    Article  PubMed  Google Scholar 

  141. Hill-Briggs F, Adler NE, Berkowitz SA, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258–79.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Childs BP. The complexity of diabetes care. Diabetes Care. 2005;18(3):130–1.

    Google Scholar 

  143. Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Presseau J. Leveraging implementation science to improve diabetes care: an overview: European Association for the Study of Diabetes; 2020.

    Google Scholar 

  145. Ingram M, Denman CA, Cornejo-Vucovich E, et al. The Meta Salud Diabetes Implementation Study: qualitative methods to assess integration of a health promotion intervention into primary care to reduce CVD risk among an underserved population with diabetes in Sonora, Mexico. Front Public Health. 2019;7:347.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Kaselitz E, Rana GK, Heisler M. Public policies and interventions for diabetes in Latin America: a scoping review. Curr Diab Rep. 2017;17(8):65.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Gutierrez-Alba G, Gonzalez-Block MA, Reyes-Morales H. [Challenges in the implementation of clinical practice guidelines in major public health institutions in Mexico: a multiple case study]. Salud Publica Mex. 2015;57(6):547–54.

    Google Scholar 

  148. Flood D, Douglas K, Goldberg V, et al. A quality improvement project using statistical process control methods for type 2 diabetes control in a resource-limited setting. Int J Qual Health Care. 2017;29(4):593–601.

    Article  PubMed  Google Scholar 

  149. Maia JX, de Sousa LA, Marcolino MS, et al. The impact of a clinical decision support system in diabetes primary care patients in a developing country. Diabetes Technol Ther. 2016;18(4):258–63.

    Article  CAS  PubMed  Google Scholar 

  150. Blasco-Blasco M, Puig-Garcia M, Piay N, Lumbreras B, Hernandez-Aguado I, Parker LA. Barriers and facilitators to successful management of type 2 diabetes mellitus in Latin America and the Caribbean: a systematic review. PLoS One. 2020;15(9):e0237542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. NICE. Type 1 diabetes in adults: diagnosis and management. London: National Institute for Health and Care Excellence; 2020.

    Google Scholar 

  152. NICE. Diabetes (type 1 and type 2) in children and young people: diagnosis and management. London: National Institute for Health and Care Excellence; 2020.

    Google Scholar 

  153. Price J, Beidas RS, Wolk CB, Genuario K, Kazak AE. Implementation science in pediatric psychology: the example of type 1 diabetes. J Pediatr Psychol. 2019;44(9):1068–73.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.

    Article  PubMed  PubMed Central  Google Scholar 

  155. Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Charalampopoulos D, Hesketh KR, Amin R, Paes VM, Viner RM, Stephenson T. Psycho-educational interventions for children and young people with type 1 diabetes in the UK: how effective are they? A systematic review and meta-analysis. PLoS One. 2017;12(6):e0179685.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Markowitz JT, Volkening LK, Laffel LM. Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr. 2014;164(6):1384–9.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Shea GR. An evaluation of “Diabetes Day” using implementation science to improve support for families of children with type 1 diabetes mellitus. Doctor of Nursing Practice (DNP) Projects. Amherst: University of Massachusetts; 2020.

    Google Scholar 

  159. IDF. Access to medicines and supplies for people with diabetes. A global survey on patients’ and professionals’ perspective. Brussels: International Diabetes Federation; 2016.

    Google Scholar 

  160. WHO. Global action plan for the prevention and control of non communicable diseases 2013-2020. Geneva: World Health Organization; 2013.

    Google Scholar 

  161. HAI/WHO. Measuring medicine prices, availability, affordability and price components: Health Action International. Geneva: World Heatlh Organization; 2008.

    Google Scholar 

  162. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9.

    Article  CAS  PubMed  Google Scholar 

  163. Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017;12(2):e0171284.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Tenorio-Mucha J, Lazo-Porras M, Hidalgo-Padilla L, Beran D, Ewen M. [Insulin: prices, availability, and affordability in public and private Peruvian pharmacies Preco, disponibilidade e acessibilidade a insulina em farmacias publicas e privadas no Peru]. Rev Panam Salud Publica. 2019;43:e85.

    Google Scholar 

  165. Leyva-Flores R, Infante-Xibille C, Gutierrez JP, Quintino-Perez F. [Persisting health and health access inequalities in Mexican indigenous population, 2006-2012]. Salud Publica Mex. 2013;55(Suppl 2):S123–8.

    Google Scholar 

  166. Pavon-Leon P, Reyes-Morales H, Martinez AJ, Mendez-Main SM, Gogeascoechea-Trejo MDC, Blazquez-Morales MSL. [Out-of-pocket expenditure by elderly adults enrolled in a public health insurance programme in Mexico]. Gac Sanit. 2017;31(4):286–91.

    Google Scholar 

  167. Emmerick IC, Luiza VL, Camacho LA, Vialle-Valentin C, Ross-Degnan D. Barriers in household access to medicines for chronic conditions in three Latin American countries. Int J Equity Health. 2015;14:115.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Luiza VL, Chaves LA, Campos MR, et al. Applying a health system perspective to the evolving Farmacia Popular medicines access programme in Brazil. BMJ Glob Health. 2017;2(Suppl 3):e000547.

    Article  PubMed  Google Scholar 

  169. Saraiva EMS, Coelho JLG, Dos Santos Figueiredo FW, do Souto RP. Medication non-adherence in patients with type 2 diabetes mellitus with full access to medicines. J Diabetes Metab Disord. 2020;19(2):1105–13.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Barcelo A, Arredondo A, Gordillo-Tobar A, Segovia J, Qiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. J Glob Health. 2017;7(2):020410.

    Article  PubMed  PubMed Central  Google Scholar 

  171. Commendatore V, Dieuzeide G, Faingold C, et al. Registry of people with diabetes in three Latin American countries: a suitable approach to evaluate the quality of health care provided to people with type 2 diabetes. Int J Clin Pract. 2013;67(12):1261–6.

    Article  CAS  PubMed  Google Scholar 

  172. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007;85(4):279–88.

    Article  PubMed  PubMed Central  Google Scholar 

  173. Ewen M, Joosse HJ, Beran D, Laing R. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Glob Health. 2019;4(3):e001410.

    Article  PubMed  PubMed Central  Google Scholar 

  174. Araujo JL, Pereira MD, de Cassia Bergamaschi C, et al. Access to medicines for diabetes treatment in Brazil: evaluation of “health has no price” program. Diabetol Metab Syndr. 2016;8:35.

    Article  PubMed  PubMed Central  Google Scholar 

  175. Dias L, Santos M, Osorio-de-Castro CGS. Public financing of human insulins in Brazil: 2009-2017. Rev Bras Epidemiol. 2020;23:e200075.

    Article  PubMed  Google Scholar 

  176. WHO. WHO model list of essential medicines. Geneva: World Health Organization, 2019.

    Google Scholar 

  177. Ball D, Ewen M, Laing R, Beran D. Insulin price components: case studies in six low/middle-income countries. BMJ Glob Health. 2019;4(5):e001705.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal. Circ Res. 2015;116(6):1058–73.

    Article  CAS  PubMed  Google Scholar 

  179. Cholesterol Treatment Trialists C, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.

    Article  Google Scholar 

  180. Aviles-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: challenges and innovative solutions to improve health outcomes across the continent. Curr Diab Rep. 2020;20(11):62.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Khatib R, McKee M, Shannon H, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;387(10013):61–9.

    Article  PubMed  Google Scholar 

  182. Collins GS, Mallett S, Omar O, Yu LM. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011;9:103.

    Article  PubMed  PubMed Central  Google Scholar 

  183. Carrillo-Larco RM, Aparcana-Granda DJ, Mejia JR, Barengo NC, Bernabe-Ortiz A. Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population-based studies. Diabet Med. 2019;36(12):1573–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Carrillo-Larco RM, Aparcana-Granda DJ, Mejia JR, Bernabé-Ortiz A. FINDRISC in Latin America: a systematic review of diagnosis and prognosis models. BMJ Open Diabetes Res Care. 2020;8(1):e001169.

    Article  PubMed  PubMed Central  Google Scholar 

  185. Bello-Chavolla OY, Vargas-Vázquez A, Antonio-Villa NE, Del Razo-Olvera FM, Elías-López D, Aguilar-Salinas CA. A high incidence of metabolic syndrome traits in Mexicans points at obesity-related metabolic dysfunction. Diabetes Metab Syndr Obes. 2021;14:1073–82.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Rojas-Martínez R, Escamilla-Núñez C, Gómez-Velasco DV, Zárate-Rojas E, Aguilar-Salinas CA. [Development and validation of a screening score for prediabetes and undiagnosed diabetes]. Salud Publica Mex. 2018;60(5):500–9.

    Google Scholar 

  187. Arellano-Campos O, Gómez-Velasco DV, Bello-Chavolla OY, et al. Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort. BMC Endocr Disord. 2019;19(1):41.

    Article  PubMed  PubMed Central  Google Scholar 

  188. Del Razo-Olvera FM, Reyes-Muñoz E, Rojas-Martínez R, et al. Development and validation of a tool for predicting type 2 diabetes in Mexican women of reproductive age. Endocrinol Diabetes Nutr. 2020;67(9):578–85.

    Article  Google Scholar 

  189. Gyberg V, De Bacquer D, Kotseva K, et al. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology. Eur Heart J. 2015;36(19):1171–7.

    Article  CAS  PubMed  Google Scholar 

  190. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care. 2001;24(3):465–71.

    Article  CAS  PubMed  Google Scholar 

  191. Lagani V, Koumakis L, Chiarugi F, Lakasing E, Tsamardinos I. A systematic review of predictive risk models for diabetes complications based on large scale clinical studies. J Diabetes Complications. 2013;27(4):407–13.

    Article  PubMed  Google Scholar 

  192. Mendoza-Herrera K, Quezada AD, Pedroza-Tobías A, Hernández-Alcaraz C, Fromow-Guerra J, Barquera S. A diabetic retinopathy screening tool for low-income adults in Mexico. Prev Chronic Dis. 2017;14:E95.

    Article  PubMed  PubMed Central  Google Scholar 

  193. Bello-Chavolla OY, Bahena-López JP, Vargas-Vázquez A, et al. Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach. BMJ Open Diabetes Res Care. 2020;8(1):e001550.

    Article  PubMed  PubMed Central  Google Scholar 

  194. Ibarra-González I, Cruz-Bautista I, Bello-Chavolla OY, et al. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics. Acta Diabetol. 2018;55(11):1151–61.

    Article  PubMed  Google Scholar 

  195. Reynoso-Noverón N, Mehta R, Almeda-Valdes P, et al. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey. Cardiovasc Diabetol. 2011;10(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  196. Bracco PA, Gregg EW, Rolka DB, et al. A nationwide analysis of the excess death attributable to diabetes in Brazil. J Glob Health. 2020;10(1):010401.

    Article  PubMed  PubMed Central  Google Scholar 

  197. Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–9.

    Article  PubMed  Google Scholar 

  198. Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7(6):442–51.

    Article  PubMed  PubMed Central  Google Scholar 

  199. Zaharia OP, Strassburger K, Strom A, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019;7(9):684–94.

    Article  PubMed  Google Scholar 

  200. Carrillo-Larco RM, Castillo-Cara M, Anza-Ramirez C, Bernabé-Ortiz A. Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean. BMJ Open Diabetes Res Care. 2021;9(1):e001889.

    Article  PubMed  PubMed Central  Google Scholar 

  201. Zhu T, Li K, Herrero P, Georgiou P. Deep learning for diabetes: a systematic review. IEEE J Biomed Health Informat. 2021;25(7):2744–57.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Public Health, Imperial College London, London, UK

    Rodrigo M. Carrillo-Larco

  2. CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru

    Rodrigo M. Carrillo-Larco, Antonio Bernabe-Ortiz, Maria Lazo-Porras, Jessica H. Zafra-Tanaka & Janeth Tenorio-Mucha

  3. Postgraduate Program in Epidemiology, School of Medicine and Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

    Paula A. Bracco

  4. Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

    Omar Yaxmehen Bello-Chavolla

  5. Division of Primary Care Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland

    David Beran

Authors
  1. Rodrigo M. Carrillo-Larco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula A. Bracco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Bernabe-Ortiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Lazo-Porras
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jessica H. Zafra-Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janeth Tenorio-Mucha
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omar Yaxmehen Bello-Chavolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. David Beran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rodrigo M. Carrillo-Larco .

Editor information

Editors and Affiliations

  1. Mexico City, Mexico

    Joel Rodriguez-Saldana

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Carrillo-Larco, R.M. et al. (2023). Diabetes Management in Latin America. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-031-25519-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-25519-9_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-25518-2

  • Online ISBN: 978-3-031-25519-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation